These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1626611)

  • 1. Drug therapy for inflammatory bowel disease: Part I.
    Linn FV; Peppercorn MA
    Am J Surg; 1992 Jul; 164(1):85-9. PubMed ID: 1626611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease.
    Van Rosendaal GM
    CMAJ; 1989 Jul; 141(2):113-23; discussion 123-4. PubMed ID: 2568163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A; Halter F
    Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Ann Intern Med; 1990 Jan; 112(1):50-60. PubMed ID: 2152845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic therapy for inflammatory bowel disease.
    Hirschfeld S; Clearfield HR
    Am Fam Physician; 1995 Jun; 51(8):1971-5. PubMed ID: 7762487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer pharmacologic agents for the therapy of inflammatory bowel disease.
    Ruderman WB
    Med Clin North Am; 1990 Jan; 74(1):133-53. PubMed ID: 2404172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current medical therapy for inflammatory bowel disease.
    Bonner GF
    South Med J; 1996 Jun; 89(6):556-66. PubMed ID: 8638193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inflammatory bowel diseases: conservative therapy].
    Bansky G
    Ther Umsch; 1991 Jul; 48(7):464-70. PubMed ID: 1926006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative tolerability of therapies for ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drug Saf; 2002; 25(8):561-82. PubMed ID: 12113642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: topical corticosteroids in inflammatory bowel disease.
    Mulder CJ; Tytgat GN
    Aliment Pharmacol Ther; 1993 Apr; 7(2):125-30. PubMed ID: 8485265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
    Van Gossum A
    Acta Gastroenterol Belg; 1992; 55(5-6):462-71. PubMed ID: 1363167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
    Fischbach W
    Leber Magen Darm; 1992 Mar; 22(2):49-55. PubMed ID: 1350043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminosalicylates: old and new.
    Hanauer SB
    Mt Sinai J Med; 1990 Oct; 57(5):283-7. PubMed ID: 1982892
    [No Abstract]   [Full Text] [Related]  

  • 16. Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease.
    Järnerot G
    Drugs; 1989 Jan; 37(1):73-86. PubMed ID: 2651087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J; Kreisel W
    Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease.
    Brzezinski A; Rankin GB; Seidner DL; Lashner BA
    Cleve Clin J Med; 1995; 62(5):317-23. PubMed ID: 7586488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminosalicylates in inflammatory bowel disease--the more the merrier?
    Forbes A
    Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1017-9. PubMed ID: 8680898
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerability of aminosalicylates in inflammatory bowel disease.
    Ishaq S; Green JR
    BioDrugs; 2001; 15(5):339-49. PubMed ID: 11437696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.